Catalyst Funds Management Pty LTD Neogenomics Inc Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Neogenomics Inc stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 2,000 shares of NEO stock, worth $32,860. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,000Holding current value
$32,860% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding NEO
# of Institutions
292Shares Held
125MCall Options Held
645KPut Options Held
120K-
Black Rock Inc. New York, NY19.7MShares$323 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$231 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$113 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$108 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$107 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $2.07B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...